{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:35:15Z","timestamp":1774312515947,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,27]]},"DOI":"10.1097\/tp.0b013e3182a203bd","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T09:28:24Z","timestamp":1377595704000},"page":"897-903","source":"Crossref","is-referenced-by-count":73,"title":["OSAKA Trial"],"prefix":"10.1097","volume":"96","author":[{"given":"Laetitia","family":"Albano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Banas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen L.","family":"Klempnauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Glyda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist.","volume":"2","author":"Schiff","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/TP.0b013e3182292426","article-title":"Lower variability of tacrolimus trough concentration after conversion from Prograf to Advagraf in stable kidney transplant recipients.","volume":"92","author":"Wu","year":"2011","journal-title":"Transplantation"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/j.1600-6143.2011.03571.x","article-title":"Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.","volume":"11","author":"Guirado","year":"2011","journal-title":"Am J Transplant"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1399-0012.2011.01544.x","article-title":"Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain.","volume":"26","author":"Morales","year":"2012","journal-title":"Clin Transplant"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e3182725532","article-title":"Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.","volume":"95","author":"Kuypers","year":"2013","journal-title":"Transplantation"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1432-2277.2011.01254.x","article-title":"Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.","volume":"24","author":"Beckebaum","year":"2011","journal-title":"Transpl Int"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/j.1600-6143.2009.02794.x","article-title":"Pharmacokinetics for once-versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial.","volume":"9","author":"Wlodarczyk","year":"2009","journal-title":"Am J Transplant"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-6143.2007.01661.x","article-title":"One-year results with extended-release tacrolimusMMF, tacrolimusMMF and cyclosporineMMF in de novo kidney transplant recipients.","volume":"7","author":"Silva","year":"2007","journal-title":"Am J Transplant"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"for the Tacrolimus Prolonged Release Renal Study Group. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.","volume":"10","author":"Kramer","year":"2010","journal-title":"Am J Transplant"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0041-1345(01)02912-8","article-title":"Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemiareperfusion renal injury.","volume":"34","author":"De Greef","year":"2002","journal-title":"Transplant Proc"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.TP.0000154915.20524.0A","article-title":"Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.","volume":"79","author":"Rostaing","year":"2005","journal-title":"Transplantation"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/01.tp.0000188300.26762.74","article-title":"Two corticosteroid-free regimenstacrolimus monotherapy after basiliximab administration and tacrolimusmycophenolate mofetilin comparison with a standard triple regimen in renal transplantation: results of the Atlas study.","volume":"80","author":"Vitko","year":"2005","journal-title":"Transplantation"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-6143.2005.01193.x","article-title":"Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study.","volume":"6","author":"Vitko","year":"2006","journal-title":"Am J Transplant"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1034\/j.1600-6143.2002.20804.x","article-title":"Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor.","volume":"2","author":"Rosengard","year":"2002","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182a203bd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:35:35Z","timestamp":1620977735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201311270-00010"}},"subtitle":["A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation"],"short-title":[],"issued":{"date-parts":[[2013,11,27]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182a203bd","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,27]]}}}